Royal College of Surgeons in Ireland, Dublin, Ireland.
Department of Orthopaedics, University of British Columbia, Vancouver, British Columbia, Canada.
J Arthroplasty. 2022 Aug;37(8):1658-1666. doi: 10.1016/j.arth.2022.03.071. Epub 2022 Mar 26.
To date, the literature has not yet revealed superiority of Minimally Invasive (MI) approaches over conventional techniques. We performed a systematic review to determine whether minimally invasive approaches are superior to conventional approaches in total hip arthroplasty for clinical and functional outcomes. We performed a meta-analysis of level 1 evidence to determine whether minimally invasive approaches are superior to conventional approaches for clinical outcomes.
All studies comparing MI approaches to conventional approaches were eligible for analysis. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were adhered to throughout this study. Registries were searched using the following MeSH terms: 'minimally invasive', 'muscle-sparing', 'THA', 'THR', 'hip arthroplasty' and 'hip replacement'. Locations searched included PubMed, the Cochrane Library, ClinicalTrials.gov, the European Union (EU) clinical trials register and the International Clinical Trials Registry Platform (World Health Organisation).
Twenty studies were identified. There were 1,282 MI total hip arthroplasty (THAs) and 1,351 conventional THAs performed. There was no difference between MI and conventional approaches for all clinical outcomes of relevance including all-cause revision (P = .959), aseptic revision (P = .894), instability (P = .894), infection (P = .669) and periprosthetic fracture (P = .940). There was also no difference in functional outcome at early or intermediate follow-up between the two groups (P = .38). In level I studies exclusively, random-effects meta-analysis demonstrated no difference in aseptic revision (P = .461) and all other outcomes between both groups.
Intermuscular MI approaches are equivalent to conventional THA approaches when considering all-cause revision, aseptic revision, infection, dislocation, fracture rates and functional outcomes. Meta-analysis of level 1 evidence supports this claim.
迄今为止,文献尚未显示微创(MI)方法优于传统技术。我们进行了系统评价,以确定微创方法在全髋关节置换术的临床和功能结果方面是否优于传统方法。我们对一级证据进行了荟萃分析,以确定微创方法在临床结果方面是否优于传统方法。
所有比较 MI 方法与传统方法的研究都符合分析标准。本研究始终遵循系统评价和荟萃分析的首选报告项目指南。使用以下 MeSH 术语搜索注册处:“微创”、“肌肉保留”、“THA”、“THR”、“髋关节置换术”和“髋关节置换”。搜索的地点包括 PubMed、Cochrane 图书馆、ClinicalTrials.gov、欧盟(EU)临床试验注册处和国际临床试验注册平台(世界卫生组织)。
确定了 20 项研究。共进行了 1282 例 MI 全髋关节置换术(THA)和 1351 例传统 THA。MI 和传统方法在所有相关临床结果方面均无差异,包括所有原因的翻修(P=0.959)、无菌性翻修(P=0.894)、不稳定(P=0.894)、感染(P=0.669)和假体周围骨折(P=0.940)。在早期或中期随访时,两组之间的功能结果也没有差异(P=0.38)。在仅为一级研究的情况下,随机效应荟萃分析表明,两组之间在无菌性翻修(P=0.461)和所有其他结果方面均无差异。
在考虑所有原因的翻修、无菌性翻修、感染、脱位、骨折率和功能结果时,肌间微创方法与传统 THA 方法相当。一级证据的荟萃分析支持这一说法。